Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned
Ultragenyx Pharmaceutical Inc. (RARE) Expense Ratio data is not available.
| Income Statement Financials | |
$166.50M |
|
$-114.95M |
|
$23.00M |
|
$143.49M |
|
$274.38M |
|
$-107.89M |
|
$-6.12M |
|
$-114.00M |
|
$-114.00M |
|
$-114.95M |
|
$-114.95M |
|
$-114.95M |
|
$-114.95M |
|
$-107.89M |
|
$-100.32M |
|
98.46M |
|
98.46M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$719.79M |
|
$255.76M |
|
$586.48M |
|
$1.31B |
|
$293.24M |
|
-- |
|
$861.74M |
|
$1.15B |
|
$151.29M |
|
$-67.85M |
|
$151.29M |
|
96.35M |
|
| Cash Flow Statement Financials | |
$-274.75M |
|
$191.06M |
|
$83.81M |
|
$184.16M |
|
$188.64M |
|
$4.49M |
|
$78.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.18% |
|
-64.80% |
|
-64.80% |
|
-- |
|
-68.47% |
|
-69.04% |
|
$-278.53M |
|
-- |
|
|
Expense Ratio |
-- |
-- |
|
0.13 |
|
0.49 |
|
1.34 |
|
67.28 |
|
-75.98% |
|
169.41% |
|
-8.80% |
|
-75.98% |
|
$1.57 |
|
$-2.83 |
|
$-2.79 |
|